Kessler F K, Ritter J K
Department of Pharmacology and Toxicology, School of Medicine, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298, USA.
Carcinogenesis. 1997 Jan;18(1):107-14. doi: 10.1093/carcin/18.1.107.
We report here that rats possess a hitherto unrecognized xenobiotic-inducible hepatic 7,8-dihydro-7,8-diol-benzo[a]pyrene (BPD) UDP-glucuronosyltransferase (UGT) activity. BPD UGT activity is induced in female F344 rat liver by treatment with the selective Phase 2 conjugation enzyme inducer oltipraz [4-methyl-5-(2-pyrazinyl)-1,2-dithiole-3-thione at 75-450 mg/kg per day for 3 days] and also by a polycyclic aromatic hydrocarbon-type inducer, beta-naphthoflavone (80 mg/kg per day for 3 days). Incubations of oltipraz-treated rat liver microsomes with racemic trans BPD (100 microM) resulted in formation of two fluorescent glucuronides that were resolved by silica thin layer chromatography (Rf 0.5 and 0.6). Incubations with either the (-) or (+) trans BPD isomers resulted in selective formation of the Rf 0.5 [designated -DS, for (-) diol specific] or Rf 0.6 [designated +DS, for (+) diol specific] glucuronide, respectively. The -DS and +DS BPD glucuronides were fluorescent under long wave ultraviolet irradiation, dependent on the presence of UDP-glucuronic acid in the incubation, and were beta-glucuronidase-sensitive. The inducing effect of oltipraz on BPD UGT activity was dose-dependent. The mean BPD UGT activity of the vehicle-treated control group was 0.05 +/- 0.02 nmol/mg per min compared with 0.53 +/- 0.07 nmol/mg per min in the group treated with oltipraz (450 mg/kg per day for 3 days) (P < 0.001). The apparent Km of the induced BPD UGT for BPD was 20 microM, suggesting that the enzyme has the capacity to bind and turnover BPD under physiological conditions. Pretreatment with beta-naphthoflavone, but not phenobarbital, induced BPD UGT activity to approximately the same extent as oltipraz. Neither oltipraz nor beta-naphthoflavone exhibited induction of BPD UGT in livers of homozygous Gunn rats, which lack functional UGT1-encoded isozymes. We conclude that the oltipraz- and polycyclic hydrocarbonresponsive BPD UGT is a member of the UGT1 family. The role of this isoform as a modifier of susceptibility to carcinogenesis elicited by B[a]P remains to be determined.
我们在此报告,大鼠具有一种迄今未被认识的外源性物质诱导的肝脏7,8 - 二氢 - 7,8 - 二醇 - 苯并[a]芘(BPD)UDP - 葡萄糖醛酸基转移酶(UGT)活性。通过用选择性的Ⅱ相结合酶诱导剂奥替普拉[4 - 甲基 - 5 -(2 - 吡嗪基)- 1,2 - 二硫杂环戊烯 - 3 - 硫酮,每天75 - 450 mg/kg,共3天]处理,以及用多环芳烃类诱导剂β - 萘黄酮(每天80 mg/kg,共3天)处理,雌性F344大鼠肝脏中的BPD UGT活性会被诱导。用外消旋反式BPD(100 μM)孵育经奥替普拉处理的大鼠肝脏微粒体,会形成两种荧光葡萄糖醛酸化物,它们通过硅胶薄层色谱法得以分离(Rf为0.5和0.6)。用(-)或(+)反式BPD异构体孵育分别导致选择性形成Rf为0.5 [命名为 - DS,代表(-)二醇特异性]或Rf为0.6 [命名为 + DS,代表(+)二醇特异性]的葡萄糖醛酸化物。- DS和 + DS BPD葡萄糖醛酸化物在长波紫外线照射下有荧光,这取决于孵育中UDP - 葡萄糖醛酸的存在,并且对β - 葡萄糖醛酸酶敏感。奥替普拉对BPD UGT活性的诱导作用呈剂量依赖性。溶剂处理的对照组的平均BPD UGT活性为0.05±0.02 nmol/mg每分钟,而用奥替普拉(每天450 mg/kg,共3天)处理的组为0.53±0.07 nmol/mg每分钟(P < 0.001)。诱导后的BPD UGT对BPD的表观Km为20 μM,这表明该酶在生理条件下有结合和转化BPD的能力。用β - 萘黄酮预处理,但不是苯巴比妥,诱导BPD UGT活性的程度与奥替普拉大致相同。奥替普拉和β - 萘黄酮在纯合冈恩大鼠的肝脏中均未表现出对BPD UGT的诱导作用,这些大鼠缺乏功能性UGT1编码的同工酶。我们得出结论,奥替普拉和多环烃反应性BPD UGT是UGT1家族的一个成员。这种同工型作为由苯并[a]芘引发的致癌易感性调节剂的作用仍有待确定。